568 related articles for article (PubMed ID: 1352705)
1. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
Nielsen D; Maare C; Skovsgaard T
Biochem Pharmacol; 1994 Jun; 47(12):2125-35. PubMed ID: 7913318
[TBL] [Abstract][Full Text] [Related]
3. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
4. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
6. The alpha 1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells.
Safa AR; Agresti M; Tamai I; Mehta ND; Vahabi S
Biochem Biophys Res Commun; 1990 Jan; 166(1):259-66. PubMed ID: 1967938
[TBL] [Abstract][Full Text] [Related]
7. Drug-transporter proteins in clinical multidrug resistance.
Scheper RJ; Broxterman HJ; Scheffer GL; Meijer CJ; Pinedo HM
Clin Chim Acta; 1992 Mar; 206(1-2):25-32. PubMed ID: 1349270
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
10. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
11. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
14. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse.
Elbling L; Berger W; Rehberger A; Waldhör T; Micksche M
FASEB J; 1993 Dec; 7(15):1499-506. PubMed ID: 7903262
[TBL] [Abstract][Full Text] [Related]
17. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
18. Genetic aspects of multidrug resistance.
Biedler JL
Cancer; 1992 Sep; 70(6 Suppl):1799-809. PubMed ID: 1355404
[TBL] [Abstract][Full Text] [Related]
19. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
Sognier MA; Zhang Y; Eberle RL; Sweet KM; Altenberg GA; Belli JA
Biochem Pharmacol; 1994 Jul; 48(2):391-401. PubMed ID: 7914406
[TBL] [Abstract][Full Text] [Related]
20. Diversity of multidrug resistance in mammalian cells.
Devine SE; Melera PW
J Biol Chem; 1994 Feb; 269(8):6133-9. PubMed ID: 7907088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]